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Abstract
Oocytes from higher chordates, including man and nearly all mammals, arrest at metaphase of the second
meiotic division before fertilization. This arrest is due to an activity that has been termed 'Cytostatic
Factor'. Cytostatic Factor maintains arrest through preventing loss in Maturation-Promoting Factor (MPF;
CDK1/cyclin B). Physiologically, Cytostatic Factor – induced metaphase arrest is only broken by a Ca2+ rise
initiated by the fertilizing sperm and results in degradation of cyclin B, the regulatory subunit of MPF
through the Anaphase-Promoting Complex/Cyclosome (APC/C). Arrest at metaphase II may therefore be
viewed as being maintained by inhibition of the APC/C, and Cytostatic Factor as being one or more
pathways, one of which inhibits the APC/C, consorting in the preservation of MPF activity.
Many studies over several years have implicated the c-Mos/MEK/MAPK pathway in the metaphase arrest of
the two most widely studied vertebrates, frog and mouse. Murine downstream components of this cascade
are not known but in frog involve members of the spindle assembly checkpoint, which act to inhibit the
APC/C. Interesting these downstream components appear not to be involved in the arrest of mouse eggs,
suggesting a lack of conservation with respect to c-Mos targets. However, the recent discovery of Emi2 as
an egg specific APC/C inhibitor whose degradation is Ca2+  dependent has greatly increased our
understanding of MetII arrest. Emi2 is involved in both the establishment and maintenance of metaphase II
arrest in frog and mouse suggesting a conservation of metaphase II arrest. Its identity as the physiologically
relevant APC/C inhibitor involved in Cytostatic Factor arrest prompted us to re-evaluate the role of the
c-Mos pathway in metaphase II arrest.
This review presents a model of Cytostatic Factor arrest, which is primarily induced by Emi2 mediated
APC/C inhibition but which also requires the c-Mos pathway to set MPF levels within physiological limits,
not too high to induce an arrest that cannot be broken, or too low to induce parthenogenesis.
Background
Meiosis is a process in which two consecutive cell divi-
sions (MI and MII) occur in the absence of an intervening
S-phase. MI is a reductional division in which homolo-
gous chromosomes are segregated, sister chromatids are
only resolved following the equational MII division (Fig
1a). On completion of MI, oocytes prevent parthenoge-
netic activation by arresting their cell cycle at metaphase
of MII (MetII) due to an activity termed Cytostatic Factor
(CSF) [1,2]. CSF blocks MetII exit until sperm break arrest
via a cytoplasmic Ca2+ signal [3-5] which induces comple-
tion of MII.
Maturation (or M-Phase) Promoting Factor (MPF; CDK1/
cyclin B) [6,7] activity drives somatic cells into mitosis
and eggs into meiosis (for reviews see [8-10]). MPF is reg-
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ulated during meiosis, oscillating in time with entry to,
and exit from MI and MII (Fig 1b). The activity of MPF can
be regulated by both CDK1 phosphorylation and cyclin B
degradation (for reviews see [2,11]). Hereafter cyclin B is
used to denote any B-type cyclin degraded at metaphase,
in frog this constitutes B1, B2, B4 and B5, while in mam-
mals B1 and B2 [12,13]. Most is known about cyclin B1
and B2 in frog and cyclin B1 in mammals. Mammalian
cyclin B1 appears to be particularly important for eggs in
Met II arrest, whereas B2 is non-essential and in all of this
review, the use of cyclin B in the context of mammalian
eggs actually refers to work carried out using cyclin B1
[8,14,15]. At M-phase exit, as would occur at fertilization,
loss of MPF is normally associated with the rapid destruc-
tion of cyclin B by anaphase [16] since CDK1 has no cat-
alytic function without its regulatory partner [17]. Cyclin
B is degraded by a Destruction-box motif (D-box) in its
primary sequence, which is recognized by the E3 ligase
Anaphase Promoting Complex/Cyclosome (APC/C). The
APC/C polyubiquitinates key cell cycle proteins such as
cyclin B, targeting them for immediate proteolysis by the
26S proteasome [18-20].
Eggs arrest at MetII with high MPF due to CSF activity (Fig
1c). The long-term stability of MPF is unique to eggs since
in a mitotic metaphase, the APC/C would be active and
cyclin B degraded. Although it is possible to exit CSF
mediated MetII arrest by inhibiting the CDK1 component
of MPF [21,22], physiologically a sperm Ca2+  signal
induces loss of cyclin B rather than CDK1 inactivation.
Interestingly in mouse eggs, the APC/C is not completely
inhibited during MetII arrest, such that eggs rely on con-
tinual cyclin B synthesis to maintain arrest [3,23,24]. Sim-
ilarly in frog eggs, the APC/C remains active enough to
degrade cyclin B [25]. At fertilization, Ca2+ stimulates
APC/C activity, in mouse about 6-fold [23], such that cyc-
The events of female meiosis Figure 1
The events of female meiosis. (A) Only one pair of homologous chromosomes is shown. After S-phase two cell divisions 
are required to produce a haploid gamete. During MI, homologous chromosomes segregate between the egg and the first 
polar body. On MI completion, eggs arrest their cell cycle at MetII. MetII exit is blocked through CSF activity, until sperm break 
the arrest. Eggs complete MII and in so doing segregate sister chromatids and extrude a second polar body. (B) MPF activity 
oscillates in time with entry to, and exit from metaphase. (C) At MetII eggs arrest their cell cycle with high levels of CSF activ-
ity.
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lin B degradation results in MPF loss. Blocking cyclin B
degradation by D-box mutation prevents exit from MetII
despite a Ca2+ signal [26,27].
Unlike MPF, the identity of CSF has never been fully
resolved, despite simultaneous identification of both
activities in a seminal paper [28]. Observations regarding
the relationship between MPF and APC/C activity have
led to the conclusion that CSF activity is likely to consti-
tute an APC/C inhibitor [2]. In mitosis, most is known
about how the APC/C is inhibited by the spindle assembly
checkpoint (SAC) proteins therefore we first discuss evi-
dence that CSF activity is due to activation of the SAC
pathway.
SAC proteins as CSF
SAC proteins were identified in budding yeast mutants
that lost ability to metaphase arrest after addition of spin-
dle poisons [29,30]. SAC proteins function in arresting
cells in metaphase by inhibiting the APC/C until all chro-
mosomes are biorientated and so under tension from
spindle microtubules (reviews see [31-33]). Vertebrate
homologues of the SAC proteins Bub1 (Budding uninhib-
ited by benzimidazole 1) Mad1 and Mad2 (Metaphase
arrest deficient 1 and 2) have been suggested to affect
MetII arrest in Xenopus eggs. Immunodepletion of these
SAC proteins from egg extracts have all been demon-
strated to block CSF arrest [34,35].
SAC components have been implicated as the down-
stream effectors the c-Mos/MEK/MAPK/p90rsk pathway,
long thought to be essential for frog CSF arrest. c-Mos
(pp39mos), a proto-oncogene from a family of kinases
functioning in signal transduction regulating cell growth
and differentiation [36], is highly expressed during germ
cell maturation, and has proposed roles throughout frog
oocyte maturation [37-43]. Functioning as a MAPK kinase
kinase (MEKK), c-Mos is important for activation of the
MAPK kinase, MEK1 [44-46]. MEK1 serves as the
upstream activator of MAPK [47-49], which switches on
the 90-kD ribosomal protein S6 kinase (p90rsk [50]). At
fertilization c-Mos is degraded [43], whilst MEK1, MAPK
and p90rsk are inactivated shortly afterwards [51,52].
The c-Mos ...p90rsk signaling cascade has been shown to
aid directly MPF activation and stabilization [53-55] mak-
ing it an ideal CSF candidate. Microinjection of c-Mos
RNA into two-cell embryos results in metaphase arrest,
and immunodepletion of c-Mos causes a loss of cleavage-
arresting activity [43]. Similarly, an injection of an active
form of MAPK [56] or constitutively-active rsk [57], into
blastomeres of two-cell embryos arrests the injected blas-
tomere in metaphase. Indeed in frog, p90rsk has been sug-
gested to be the only MAPK substrate needed for cyclin B
re-accumulation on entry to MetII, MetII spindle forma-
tion, and CSF arrest [57,58]. This is supported by the fact
that c-Mos protein is unable to establish CSF arrest in frog
egg extracts immunodepleted of p90rsk [59].
The SAC component Bub1 is phosphorlyated and acti-
vated by p90rsk [60]. Bub1 [34], Mad1 and Mad2 [35] all
appear to be required downstream of c-Mos given that the
immunodepletion of these proteins blocked the establish-
ment of CSF arrest by c-Mos in frog egg extracts. Such stud-
ies suggest a model in which CSF arrest by c-Mos is
mediated by Bub1, Mad1 and Mad2 proteins.
From the above it appears that a well-defined CSF path-
way has been identified in frog. However, studying SAC
components maybe somewhat misleading with respect to
identifying CSF. Although CSF activity and the SAC are
similar in being able to induce metaphase arrest through
APC/C inhibition, they may use different signalling path-
ways. Any arrest must be reversed by Ca2+ to prove physi-
ological relevance with respect to CSF. A further issue is
how CSF arrest can be achieved at MetII but not at MI met-
aphase (MetI) since many components of the c-Mos path-
way are present and active at MetI. For example, c-Mos,
MAPK, p90rsk and Bub1 are essential for suppression of S-
phase between meiotic divisions [43,58,61,62] yet do not
block eggs at MetI. A possible explanation is the involve-
ment of cyclin E/cdk2, both of which are synthesized dur-
ing MII [63] and inhibit the APC/C.
In frog eggs cyclin E/Cdk2 activity has been reported to
play an essential role in CSF arrest. Cyclin E/Cdk2, like c-
Mos, can establish metaphase arrest in egg extracts
[34,63]. Cdk2 antisense prevents CSF arrest [64] and
recombinant cyclin E/Cdk2 causes metaphase arrest in egg
extracts even in the absence of c-Mos [34]. The two path-
ways (c-Mos and cyclin E/cdk2) are therefore suggested to
be independent of each other but both appear to inhibit
the APC/C. CSF activity therefore may result from the
coexpression of cyclin E/Cdk2 with the c-Mos/MEK/
MAPK/p90rsk pathway. However, the role of cyclin E/
cdk2 in CSF arrest remains to be fully elucidated since
inhibiting cdk2 [65], and ablation of cyclin E [66] have
both been reported not disrupt CSF arrest.
Once CSF arrest has been established then many of the
above proteins seem no longer required for maintenance
(p90rsk, Mad2, Bub1 and cyclin E/cdk2 are all dispensa-
ble for maintenance [34,35,59]). This suggests that these
proteins act upstream or independently of other effectors
of CSF activity. SAC proteins may be essential to improve
the efficiency of APC/C inhibition on entry into MetII
arrest, yet appear redundant in the maintenance of arrest.
Whilst the c-Mos/MEK/MAPK/p90rsk/(SAC proteins)
pathway is well established in the frog, its role in mamma-
lian eggs is less clear. Although eggs from c-Mos knockout
mice eventually undergo parthenogenetic activation
[67,68], they do MetII arrest, remaining there for 2–4 h,
before going on to exit MII [69]. This suggests that whilst
c-Mos is critical for protracted MetII arrest, it is not
required for its establishment. Loss of MEK or MAPK
activity also results in parthenogenesis [21] suggesting asCell Division 2007, 2:4 http://www.celldiv.com/content/2/1/4
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in frog they are downstream components of the c-Mos
pathway. However, p90rsk plays no essential role in
mouse because eggs from Rsk knockouts arrest at MetII
[70]. Furthermore SAC proteins do not mediate CSF activ-
ity since mouse eggs expressing dominant negative
mutants of Bub1 and Mad2 arrest at MetII [71]. Therefore
the c-Mos/MEK/MAPK pathway acting independently of
p90rsk is likely only to be involved in helping maintain-
ing MetII arrest in mammals, rather than having a direct
role in its establishment.
Emi2 as CSF
When considering all of the above, one may conclude that
the c-Mos pathway is unlikely to constitute fully CSF.
Recently an egg-specific protein Emi2 (or Early mitotic
inhibitor 1-related protein 1; Erp1) has been identified.
Emi2 degradation is Ca2+ dependent and likely functions
to both establish and maintain CSF arrest by APC/C inhi-
bition [72-76]. Interest in Emi2 was generated from work
on a related protein Emi1, which prevents premature
APC/C activation in G2 of the mitotic cell cycle by binding
to the APC/C activator protein Cdc20 [77]. Although
Emi1 itself was initially suggested to be involved in MetII
arrest [78], this is now known not to be so [79], and was
probably due to antibody cross-reactivity between the two
Emi proteins [76].
Emi2 is a substrate of a polo-like kinase (Plk), which plays
a crucial role in regulating progression through M phase
[80], allowing timely activation of the APC/C at the onset
of anaphase [81-83]. In frog eggs a role for Plx1 in Ca2+-
mediated APC/C activation was demonstrated several
years ago [81] with the authors proposing the existence of
a Plx1-regulated inhibitor of the APC/C active at MetII
which was inactivated by Plx1 at fertilization. A later
yeast-two hybrid screen for Plx1-interacting proteins iden-
tified Emi2. Like CSF activity, Emi2 accumulates during
egg maturation, is present and stable in CSF arrested egg
extracts, but is rapidly degraded on Ca2+ addition [75].
Plx1 is fully active at metaphase [84], yet at MetII it does
not remove inhibition of the APC/C until at fertilization.
At fertilization the target of Ca2+ is calmodulin-dependent
protein kinase II (CamKII) [85,86], which acts a priming
kinase, directly phosphorylating Emi2 [72]. Plx1 further
phosphorylates Emi2 [72-74], to generate a degron which
is recognised by the SCF ubiquitin ligase, resulting in
Emi2 polyubiquitination and destruction [74]. Therefore
APC/C inhibition is only removed once both CamKII and
Plx1 are active.
In mammals, like frog, a Ca2+ signal breaks MetII arrest
through a signalling pathway involving CamKII and acti-
vation the APC/C [87-89]. Although the full mechanism
of Emi2 degradation has not yet been demonstrated in
mouse, like frog, mouse Emi2 contains specific motifs for
phosphorylation by both Plk and CamKII. Given that
ablation of Emi2 in MetII arrested mouse eggs results in
parthenogenetic activation [90], it would appear that the
target of CamKII in mouse eggs is also Emi2. Supporting
a role in maintaining CSF activity, Emi2 is extremely sta-
ble in MetII eggs, yet rapidly degraded by Ca2+ [91]. As
predicted for an APC/C inhibitor, it follows that on
release from MetII, Emi2 destruction precedes that of cyc-
lin B [91]. These findings taken together demonstrate an
essential role for Emi2 in the maintenance of MetII arrest.
On entry into MetII Emi2 is also important for APC/C
inhibition, allowing cyclin B, and so MPF, accumulation.
Emi2 levels are low in oocyte maturation, presumably to
allow the APC/C to be active and permit passage through
MI [91]. Emi2 morpholinos added to maturing mouse
oocytes prevent cyclin B re-accumulation on entry into
MII and eggs consequentially fail to form MetII spindles,
eventually decondensing their chromatin[91]. In this
work, MetII arrest was rescued by re-addition of Emi2,
expression of a D-box mutant of cyclin B or by addition of
nocodazaole to induce a SAC mediated arrest. Emi2 also
appears to be essential for the establishment of arrest in
frog eggs [92,93] suggesting a conserved mechanism in
vertebrates.
Conclusion: Our model, MPF stabilisation plus 
APC/C inhibition equals CSF
A unifying hypothesis would be useful which invokes
most of the CSF candidates described in both mouse and
Model of the regulation of MetII arrest in mammalian eggs Figure 2
Model of the regulation of MetII arrest in mamma-
lian eggs. High MPF activity is essential for MetII arrest and 
may be maintained via separate pathways; direct inhibition of 
the APC/C, and direct stabilization of MPF. The pathway 
which involves Emi2-mediated CSF arrest is shown in solid 
lines. In mouse eggs, the c-Mos pathway is not mediated by 
p90rsk, so its downstream targets remain obscure (dashed 
lines), but potential target points are shown as either inhibi-
tion of the APC/C or inhibition of Emi2 degradation. MPF 
activity may negatively regulate the c-Mos pathway, as based 
on studies from frog [94]. See text for further details.
#YCLIN "
#$+
#$+
!0#
%MI
C
-OS
-%+
-!0+
(IGH -0&
-ET)) ARREST
,OW -0& 
%XIT FROM -)) 
#AM+)) 0LK
3#&Cell Division 2007, 2:4 http://www.celldiv.com/content/2/1/4
Page 5 of 7
(page number not for citation purposes)
frog (the c-Mos/MEK/MAPK/p90rsk/Bub1; Mad1 and
Mad2; cyclin E1/cdk2 and Emi2). Having a completely
unified mechanism however looks unlikely given that the
Mos/MAPK pathway in mouse does not involve p90rsk.
To establish whether Emi2 and the c-Mos pathway func-
tion independently remains important but here we go on
to suggest a working model of how these two pathways
interact.
We propose that MetII arrest is established through Emi2-
mediated APC/C inhibition, and maintained both by
Emi2 and the c-Mos/MAPK pathway, which acts to stabi-
lise MPF (Fig 2). The exact nature of the effect of the c-Mos
pathway on MPF stability is still to be fully resolved how-
ever Yamamoto et al. [94] in frog eggs showed that when
MPF activity reaches a critical lower level, the c-Mos/
MAPK pathway suppresses cyclin B degradation in order
to elevate MPF levels; whilst elevation of MPF beyond a
critical upper level activates APC/C dependent cyclin B
degradation [94]. This suggests that Mos may help set the
level of MPF activity. A CSF-arrested frog egg extract will
exit MetII without cyclin B loss or a Ca2+ stimulus when
Greatwall kinase, known to positively affect MPF activity,
is immunodepleted [95]. This illustrates the point that
when considering the protacted nature of MetII arrest, one
must consider mechanisms in the egg which are designed
to respond to the sperm (Emi2 mediated APC/C inactiv-
ity) as well as those designed to keep MPF active until the
time of fertilization. Our suggestion is that the c-Mos
pathway may contribute to this second mechanism.
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